XSHG
603067
Market cap4.32bUSD
Oct 09, Last price
42.31CNY
1D
10.01%
1Q
5.09%
Jan 2017
192.40%
IPO
754.75%
Name
Hubei Zhenhua Chemical Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hubei Zhenhua Chemical Co.,Ltd. primarily conducts its operations within China, specializing in the entire lifecycle of chromium salt products, from their development and manufacturing to their ultimate sale and distribution. Their comprehensive product portfolio includes a wide array of chromium-based compounds such as sodium bichromate, various forms of chromic acid anhydride (both crystalline and liquid), chrome oxide green, and potassium dichromate. Beyond these core offerings, the company also supplies vitamin K3, anhydrous sodium sulphate, and aluminium hydroxide. The firm boasts an international presence, exporting its goods to diverse global markets across Europe, the United States, Africa, and Southeast Asia. Established in 1967, Hubei Zhenhua Chemical Co.,Ltd. is headquartered in Huangshi, China, and was previously known as Huanghsi Zhenhua Chemical Industry Co., Ltd.
Key people
Fan Yang
Chief Financial Officer · since 2018
Yusheng Ke
General Manager, Director
Yilang Shi
Deputy General Manager
Daxue Shi
Deputy General Manager
Qianyan Chen
Deputy General Manager, Secretary of the Board · since 2018
Zaihua Cai
Chairman of the Board
Zunyou Ke
Deputy General Manager, Director · since 2018
Guobin Ruan
Director
Hao Zhang
Director · since 2017
Handong Xu
Independent Director
Yapin Zeng
Independent Director
Headquarters & legal address
湖北省黄石市西塞山区黄石大道668号
黄石市, HB 435001
CN
黄石市, HB 435001
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||